Kilitch Drugs (India) Ltd Share Price (KILITCH)
as on
| Source : NSE
Kilitch Drugs (India) Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's High
₹403.95₹4070.76%
Upside
52 Week's Low
52 Week's High
₹294.07₹500
27.20%
Downside
23.78%
Upside
| Market Stats | |
| Previous Close | ₹409.15 |
| Open | ₹403.95 |
| Volume | 3,221.00 |
| Upper Circuit | ₹417.30 |
| Lower Circuit | ₹401.00 |
| Day's Low | ₹403.95 |
| Day's High | ₹407 |
| 52 Week Low | ₹294.07 |
| 52 Week High | ₹500 |
| Returns % | |
| 1 Month Return | -7.95 % |
| 3 Month Return | -11.07 % |
| 1 Year Return | + 22.37 % |
| 3 Year Return | + 152.33 % |
| 5 Year Return | + 319 % |
Kilitch Drugs (India) Ltd Stock Fundamentals & Key Indicators
Check Kilitch Drugs (India) Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹715.23 Cr
Return on Equity (ROE)
8.39
PE Ratio (TTM)
24
Return on capital employed (ROCE)
10.74
Industry PE ratio
43.37
Beta (LTM)
0.65
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
2.56
Quarterly Earnings Growth YOY
1954.55
EPS (TTM)
8.25944845673576
Sector
Pharmaceuticals
Book Value
107.27
Technical Analysis
Bearish
View Technical Analysis
Kilitch Drugs (India) Ltd Stock's Interest Amongst Investors
Kilitch Drugs (India) Ltd Stock Valuation
Track how Kilitch Drugs (India) Ltd P/E has moved over time to understand its valuation trends.
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (24.00x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (371.68x)
October 16, 2020
Today’s Price to Earnings Ratio: 24.00x
Kilitch Drugs (India) Ltd Financial Results
Get the annual and quarterly financial summary of Kilitch Drugs (India) Ltd, including revenue, profit, loss and more.
Kilitch Drugs (India) Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Kilitch Drugs (India) Ltd.
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit jumped 126.12% since last year same period to ₹3.03Cr in the Q1 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -70.87% fall in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.12%.
Read More about Dividends
Kilitch Drugs (India) Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kilitch Drugs (India) Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.76% | ||
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 715.23 | 63.8% | 0.58 | 13 | 154 | |
| NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
| NA | 509.12 | 22.09% | 0.00 | NA | NA | |
| NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
| NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Kilitch Drugs (India) Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Kilitch Drugs (India) Ltd.
Kilitch Drugs Targets Rs 1,000 Crore Revenue Growth - 03 Jul, 2025
Kilitch Drugs aims to achieve Rs 1,000 crore in revenue within 3-4 years, driven by a new Khopoli manufacturing facility and expansion into regulated markets. The company plans to invest Rs 125 crore in the facility, which will enhance production capacity and reduce outsourcing costs. Kilitch expects significant growth in revenue and margins, particularly in FY27, while maintaining a strong presence in Africa.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 0.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Jun 2025 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 62.92 Cr → 45.7 Cr (in ₹), with an average decrease of 27.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, KILITCH stock has moved down by -1.9%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 10.4 Cr → 3.03 Cr (in ₹), with an average decrease of 70.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 30.77% to 30.76% in Jun 2025 quarter
About Kilitch Drugs (India) Ltd
Revenue: ₹43.14Cr as on June 2025 (Q1 FY26)
Net Profit: ₹2.26Cr as on June 2025 (Q1 FY26)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Mukund P Mehta |
| E-voting on shares | Click here to vote |
FAQs
What is Kilitch Drugs (India) Ltd share price today?
Kilitch Drugs (India) Ltd share price today stands at ₹403.95, Open: ₹403.95, Previous Close: ₹409.15, High: ₹407, Low: ₹403.95, 52 Week High: ₹500, 52 Week Low: ₹294.07 as on .
How to buy Kilitch Drugs (India) Ltd shares ?
To buy Kilitch Drugs (India) Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Kilitch Drugs (India) Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Kilitch Drugs (India) Ltd?
Today's traded volume of Kilitch Drugs (India) Ltd is 3,221.00. Which means that 3,221.00 shares of Kilitch Drugs (India) Ltd were bought and sold on the stock market during today's trading session.
What is Kilitch Drugs (India) Ltd's market cap today?
Today's market capitalisation of Kilitch Drugs (India) Ltd is ₹715.23 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd’s 52 week high is ₹500 and 52 week low is ₹294.07. The current share price of Kilitch Drugs (India) Ltd is ₹403.95, which is -19.21% down from its 52 week high and 37.37% up from its 52 week low.